This increase of activity was not relevant to the RIPK2 expression level in IBC as there was no significant difference in RIPK2 mRNA expression observed between IBC and non-IBC in cell lines (Figure 6a) and patient samples (Figure 6b) according to the GEO (Gene Expression Omnibus) datasets. This evidence concerns the gene RIPK2 and inflammatory breast carcinoma.